As presented in Table 1, clinically significant SNPs identified in AATD include variations in NOS3, GSTP1, TNF-α, IL10, CHRNA3, IREB2, mEH, and immune-related genes. This evidence concerns the gene CHRNA3 and alpha 1-antitrypsin deficiency.